Summary of all the Indicators
Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Xeris Pharmaceuticals’s (2B30) Moving Averages Convergence Divergence (MACD) indicator is 0.53, suggesting Xeris Pharmaceuticals is a Sell.
Xeris Pharmaceuticals’s (2B30) 20-Day exponential moving average is 8.77, while Xeris Pharmaceuticals’s (2B30) share price is €7.14, making it a Buy.
Xeris Pharmaceuticals’s (2B30) 50-Day exponential moving average is 8.02, while Xeris Pharmaceuticals’s (2B30) share price is €7.14, making it a Buy.
Xeris Pharmaceuticals (2B30) Pivot Points
Classic
9.77
9.77
9.77
9.77
9.77
9.77
9.77
Fibonacci
9.77
9.77
9.77
9.77
9.77
9.77
9.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Xeris Pharmaceuticals (2B30) Moving Averages
MA5
9.41Sell
9.42Sell
MA10
9.18Buy
9.19Buy
MA20
8.78Buy
8.77Buy
MA50
7.78Buy
8.02Buy
MA100
7.24Buy
7.39Buy
MA200
6.31Buy
6.75Buy
Xeris Pharmaceuticals’s (2B30) 10-Day exponential moving average is 9.19, while Xeris Pharmaceuticals’s (2B30) share price is €7.14, making it a Buy.
Xeris Pharmaceuticals’s (2B30) 100-Day exponential moving average is 7.39, while Xeris Pharmaceuticals’s (2B30) share price is €7.14, making it a Buy.
Xeris Pharmaceuticals’s (2B30) stock price is €7.14 and Xeris Pharmaceuticals’s (2B30) 50-day simple moving average is 7.78, creating a Buy signal.
Xeris Pharmaceuticals’s (2B30) stock price is €7.14 and Xeris Pharmaceuticals’s (2B30) 100-day simple moving average is 7.24, creating a Buy signal.
Xeris Pharmaceuticals’s (2B30) stock price is €7.14 and Xeris Pharmaceuticals’s (2B30) 200-day simple moving average is 6.31, creating a Buy signal.
Xeris Pharmaceuticals (2B30) Technical Indicators
RSI (14)
61.93
Neutral
STOCH (9,6)
81.04
Sell
STOCHRSI (14)
86.46
Sell
MACD (12,26)
0.53
Sell
ADX (14)
31.56
Neutral
Williams %R
-29.63
Buy
CCI (14)
92.58
Neutral
ATR (14)
0.28
-
Ultimate Oscillator
59.56
Neutral
ROC
16.03
Buy
Xeris Pharmaceuticals’s (2B30) Relative Strength Index (RSI) is 61.93, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Trend Strength Indicator (ADX) is 31.56, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Commodity Channel Index (CCI) is 92.58, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Price Rate of Change (ROC) is 16.03, creating a Buy signal.
FAQ
Is 2B30 a Buy, Hold, or Sell?
Based on 2B30’s technical indicators, 2B30 is a Buy.
What is 2B30’s RSI (14)?
2B30’s RSI (14) is 61.93, which suggests 2B30 is a Neutral.
What is 2B30’s MACD?
2B30’s MACD is 0.53, which suggests 2B30 is a Sell.
What is 2B30’s 5-day moving average?
2B30’s 5-day moving average is 9.41, which suggests 2B30 is a Sell.
What is 2B30’s 20-day moving average?
2B30 20-day moving average is 8.78, which suggests 2B30 is a Buy.
What is 2B30’s 50-day moving average?
2B30’s 50-day moving average is 7.78, which suggests 2B30 is a Buy.
What is 2B30’s 200-day moving average?
2B30’s 200-day moving average is 6.31, which suggests 2B30 is a Buy.
What is 2B30’s Williams % R (14)?
2B30’s Williams % R (14) is -29.63, which suggests 2B30 is a Buy.
What is 2B30’s CCI (14)?
2B30’s CCI (14) is 92.58, which suggests 2B30 is a Neutral.
What is the share price of Xeris Pharmaceuticals?
Xeris Pharmaceuticals's share price is N/A€.